Dynamics of Effector -Tumor- Interleukin-2 Interactions with Monod-Haldane Immune Response and Treatments
From MaRDI portal
Publication:3297312
DOI10.1007/978-3-030-34152-7_46zbMath1444.92021OpenAlexW3004449369MaRDI QIDQ3297312
Parthasakha Das, Pritha Das, Sayan Mukherjee
Publication date: 3 July 2020
Published in: Recent Advances in Intelligent Information Systems and Applied Mathematics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1007/978-3-030-34152-7_46
Bifurcation theory for ordinary differential equations (34C23) Stability of solutions to ordinary differential equations (34D20) Pathology, pathophysiology (92C32)
Related Items (3)
Optimal treatment strategies for delayed cancer-immune system with multiple therapeutic approach ⋮ Optimal control strategy for cancer remission using combinatorial therapy: a mathematical model-based approach ⋮ Control of Nipah virus outbreak in commercial pig-farm with biosecurity and culling
Cites Work
- Unnamed Item
- A structural methodology for modeling immune-tumor interactions including pro- and anti-tumor factors for clinical applications
- Modeling immunotherapy of the tumor -- immune interaction
- An investigation on Michaelis-Menten kinetics based complex dynamics of tumor-immune interaction
- Stochastic dynamics of Michaelis-Menten kinetics based tumor-immune interactions
- An investigation on Monod-Haldane immune response based tumor-effector-interleukin-2 interactions with treatments
- Modeling the dichotomy of the immune response to cancer: cytotoxic effects and tumor-promoting inflammation
- A survey of models for tumor-immune system dynamics
- The promoting role of a tumour-secreted chemorepellent in self-metastatic tumour progression
- Immunotherapy with Interleukin-2: A Study Based on Mathematical Modeling
This page was built for publication: Dynamics of Effector -Tumor- Interleukin-2 Interactions with Monod-Haldane Immune Response and Treatments
